Charles Explorer logo
🇨🇿

Dynamics of Glucose Concentration during the Initiation of Ketogenic Diet Treatment in Children with Refractory Epilepsy: Results of Continuous Glucose Monitoring

Publikace na 3. lékařská fakulta, 1. lékařská fakulta, Fakulta tělesné výchovy a sportu, 2. lékařská fakulta |
2023

Tento text není v aktuálním jazyce dostupný. Zobrazuje se verze "en".Abstrakt

OBJECTIVE: The ketogenic diet (KD) is a diet low in carbohydrates and rich in fats which has long been used to treat refractory epilepsy. The metabolic changes related to the KD may increase the risk of hypoglycemia, especially during the first days.

The study focused on the impact of KD initiation on glycemia in non-diabetic patients with refractory epilepsy. METHODS: The subjects were 10 paediatric patients (6 boys, mean age 6,1+-2,4 years), treated for intractable epilepsy.

Blinded continuous glucose monitoring system (CGM) Dexcom G4 was used.. Patients started on their regular diet in the first 36 hours of monitoring, followed by an increase in lipids intake and a gradual reduction of carbohydrates (relations 1:1;2:1;3:1;3,5:1).

We analysed changes in glycemia during fat: non fat ratio changes using a generalized linear model. RESULTS: The mean monitored time per person was 6 days, 10 hours and 44 minutes.

The mean+-SD glycemia for the regular diet was 4.84+-0.20 mmol/l, for the carbohydrates/fat ratio of 1:1 it was 4.03+-0.16, for the ratio of 2:1 it was 3.57+-0.10, for the ratio 3:1 it was 3.39+-0.13 and for the final ratio of 3.5:1 it was 2.79+-0,06 mmol/l (p< 0,001). The portions of time spent in glycemia <=3.5 mmol/l (<=2.5 mmol/l respectively) were: on the normal diet 0.88% (0.31%) of the monitored period, during 1:1 KD ratio 1.92% (0.95%), during 2:1 ratio 3.18% (1.02%), and during 3:1 and 3.5:1 ratios 13.64% (2.36%) of the monitored time (p<0,05).

SIGNIFICANCE: CGM shows the dynamic of glucose concentration in ketogenic diet treatment initiation. It may be a useful tool to control the effects of this diet on glucose metabolism, especially in hypoglycemia detection.